… We studied patients with SR aGVHD, comparing extracorporeal photopheresis (ECP; n =
57) and anticytokine therapy (n = 41). In multivariate analyses, ECP, adjusted for steroid dose (…

… Extracorporeal photopheresis (ECP) is an established treatment strategy in steroid-refractory
graft-versus-host disease (GVHD). This study's main objective was to analyze the clinical …

… studies is impressive and is in line with what was reported by Jagasia and colleagues 19 in
a multicenter comparative analysis, … Several studies in the literature, including the article by …

… multicenter analysis, ECP has shown response rates of 80% in acute and chronic GVHD
patients (41). A meta-analysis reviewed 7 prospective studies … controlled multicenter studies (42)…

… A multicenter comparative analysis of ECP (n = 57) versus anticytokine therapy with inolimumab
or etanercept (n = 41) as a second-line treatment for steroid refractory aGvHD reported …

… -host disease treated by extracorporeal photochemotherapy: a retrospective study according
to … Efficacy of bimonthly extracorporeal photopheresis in refractory chronic mucocutaneous …

… this study is to analyze outcomes of ECP in a large multicenter … arises from the multicenter
nature of the study, as clinical … Another limitation of our retrospective multicenter analysis is that …

… multicenter phase 2 study to evaluate the safety and efficacy of prophylactic Extracorporeal
Photopheresis (ECP… This study shows encouraging results with low acute and chronic GVHD …

… We undertook a prospective randomized controlled trial of extracorporeal photopheresis to
evaluate the effects of ECP treatment on the cutaneous and extracutaneous manifestations of …

… Aim of this study was to describe the real-world use of extracorporeal photopheresis (ECP)
and assess its impact on clinical outcomes in the modern era of heart transplantation. …